Epithalon vs NAD+: An Overview
Epithalon and NAD+ are both referenced heavily in longevity and cellular-aging research, but they belong to entirely different molecular categories. One is a short peptide bioregulator; the other is a fundamental metabolic cofactor. Comparing them clarifies why researchers approach each through different experimental frameworks.
Epithalon (also written epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) modeled on epithalamin, a pineal-gland extract, and is studied in the research literature in connection with telomere biology and the enzyme telomerase. NAD+ (nicotinamide adenine dinucleotide) is not a peptide at all but a ubiquitous coenzyme central to cellular redox reactions and to the activity of sirtuins and other NAD-dependent enzymes. Their comparison is therefore one of a targeted peptide bioregulator versus a broad metabolic cofactor.
This article compares Epithalon (50mg) and NAD+ (1000mg) strictly at the level of structure, mechanism, and research context. For research use only; not for human or animal consumption.
Recommended Products
Longevity Mechanisms and Structure
The defining difference is category: Epithalon is a defined four-residue peptide studied for a specific, telomere-related mechanism, while NAD+ is a small-molecule dinucleotide cofactor involved in a wide array of cellular metabolic and signaling reactions. In longevity research these represent two distinct entry points into the aging question, one via peptide bioregulation and one via metabolic-cofactor availability.
| Attribute | Epithalon | NAD+ |
|---|---|---|
| Molecular type | Tetrapeptide (Ala-Glu-Asp-Gly) | Dinucleotide coenzyme |
| Origin basis | Pineal peptide (epithalamin) model | Endogenous metabolic cofactor |
| Research focus | Telomere/telomerase biology | Redox reactions, sirtuin activity |
| Scope of action | Targeted bioregulator | Broad cellular metabolism |
| Class | Peptide bioregulator | Non-peptide cofactor |
Because Epithalon acts as a discrete peptide and NAD+ functions as a broadly used metabolic cofactor, researchers rarely treat them as substitutes; instead they represent complementary mechanisms in the study of cellular aging. Investigators building a longevity-research panel often add a mitochondrial-targeted compound such as SS-31 (50mg), studied in the context of mitochondrial and cardiolipin biology, to span an additional aging-related pathway. Given that one is a lyophilized peptide and the other a nucleotide cofactor, their solubility, stability, and storage profiles are quite different and must be handled independently. For the broader landscape, see the pillar overview on longevity and anti-aging research peptides.
How Researchers Approach These
Selection depends on the aging mechanism under investigation. Research centered on telomere and telomerase biology references Epithalon, whose defining feature is its association with that pathway. Work focused on cellular redox balance, sirtuin activity, or metabolic-cofactor availability references NAD+. Because they act through fundamentally different mechanisms, comparative longevity studies often include both, and sometimes a mitochondrial compound such as SS-31, to map several aging-related pathways at once.
Handling differs by molecule. Epithalon is a lyophilized peptide reconstituted with an appropriate sterile diluent and kept cold. NAD+ is a nucleotide cofactor with its own stability considerations and is supplied at a larger 1000mg scale reflecting different working quantities. For both, store cold, protect from light, minimize freeze-thaw cycles, and calculate concentrations per compound given their very different molecular weights. Document lot and preparation details for reproducibility. Review Epithalon (50mg) and NAD+ (1000mg) specifications before designing a study. For research use only.